• Home
  • Latest
    • News
    • North America
    • Europe
    • Asia
    • Middle East
    • Global
  • Fortune 500
    • Fortune 500 U.S.
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
  • Finance
    • Economy
    • Banking
    • Personal Finance
    • Investing
    • Real Estate
    • Energy
    • Crypto
  • Tech
    • Big Tech
    • Startups & Venture
    • AI
    • Innovation
    • Cybersecurity
  • Leadership
    • Future Of Work
    • Success
    • C-Suite
    • Workplace Culture
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Health
    • Travel & Leisure
    • Education
  • Rankings
    • Great Place To Work
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Press Releases
    • Video
    • Podcasts
  • Home
  • Latest
    • Latest
    • News
    • North America
    • Europe
    • Asia
    • Middle East
    • Global
  • Fortune 500
    • Fortune 500
    • Fortune 500 U.S.
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
  • Finance
    • Finance
    • Economy
    • Banking
    • Personal Finance
    • Investing
    • Real Estate
    • Energy
    • Crypto
  • Tech
    • Tech
    • Big Tech
    • Startups & Venture
    • AI
    • Innovation
    • Cybersecurity
  • Leadership
    • Leadership
    • Future Of Work
    • Success
    • C-Suite
    • Workplace Culture
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Health
    • Travel & Leisure
    • Education
  • Rankings
    • Rankings
    • Great Place To Work
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Press Releases
    • Video
    • Podcasts
  1. home
  1. home
  2. Biotech

Biotech

Page 18 of 19

Bristol Myers
Finance

Flexus goes from zero to $1.25 billion in 17 months

By Dan Primack
February 24, 2015
Third Rock Ventures: Giving birth to a new generation of biotechs
Tech

Third Rock Ventures: Giving birth to a new generation of biotechs

By Jennifer Alsever
February 19, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
Finance

After Allergan loss, is Valeant dumpster diving?

By Jen Wieczner
January 31, 2015
A powerful new super antibiotic may be right under our feet

A powerful new super antibiotic may be right under our feet

By Laura Lorenzetti
January 8, 2015
The $3 billion startup that wants to help you to make medicines in your own body

The $3 billion startup that wants to help you to make medicines in your own body

By Dan Primack
January 8, 2015
Davos World Economic Forum (WEF) 2011
Leadership

Sean Parker gives $24 million to Stanford to cure allergies

By Jen Wieczner
December 17, 2014
2015 Investor’s Guide: Don’t buy this, buy that—Technology and Biotech
Finance

2015 Investor’s Guide: Don’t buy this, buy that—Technology and Biotech

By Jen Wieczner and Lauren Silva Laughlin
December 4, 2014
Daniel Loeb urges Amgen to split into two companies
Finance

Daniel Loeb urges Amgen to split into two companies

By Reuters
October 21, 2014
Michelle Dipp, CEO Of OvaScience
MPW

OvaScience CEO talks Apple, Facebook and the $9 billion fertility market

By Matt McCue
October 16, 2014
How to stop Ebola
Features

How to stop Ebola

By Erika Fry
September 4, 2014
Catalent delivers with $871 million biotech IPO
Finance

Catalent delivers with $871 million biotech IPO

By Laura Lorenzetti
July 31, 2014
Wall Street’s next bet: Cures for rare diseases
Features

Wall Street’s next bet: Cures for rare diseases

By Andrew W. Lo
January 21, 2014
The big bull backup
Features

The big bull backup

By Anne VanderMey
September 19, 2013
Fortune
Finance

Lessons from the frontlines of early-stage biotech investing

By Fortune Editors
February 12, 2013
Fortune

Stem cell dollars: California leads the way

By Fortune Editors, Brett Krasnove and Brett Krasnove
September 28, 2012

Most Popular

  • Success
    The scientist who helped create AI says it’s only ‘a matter of time’ before every single job is wiped out—even safer...
    By Orianna Rosa Royle
  • Success
    As graduates face a ‘jobpocalypse,’ Goldman Sachs exec tells Gen Z they need to know their commercial impact 
    By Preston Fore
  • Economy
    James Talarico says the biggest 'welfare queens' in America are 'the giant corporations that don't pay a penny in...
    By Dave Smith
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • MPW
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms of Use
  • Single Issues for Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work at Fortune
  • Diversity and Inclusion
  • Terms and Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.